Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Genzyme picture

Genzyme to close UK site

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …
News

The NHS, a postcard from the frontline

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …
Feature

Astellas hires senior vice president for new Global Medical Affairs organisation

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations …
Appointment

Alex Gorsky named new chief executive of J&J

February 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Appointment
Takeda image

Takeda’s ulcerative colitis drug gets Phase III boost

February 22, 2012 Research and Development

Takeda’s ulcerative colitis drug vedolizumab has succeeded in a late-stage trial.  The Phase III trial studied vedolizumab in 895 patients …
News
Georg Toufar

Working Life: Georg Toufar, director, Mundipharma

February 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Georg Toufar, Mundipharma, Working Life

Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT).  …
Feature

Bayer eye drug succeeds in long-term study

February 21, 2012 Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD

Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition.  The Phase III …
News

Contract research news in brief

February 21, 2012 Research and Development Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …
News

Setback for Gilead hep C candidate

February 20, 2012 Research and Development, Sales and Marketing ELECTRON, GS-7977, Gilead, Pharmasset

Gilead’s investigational hepatitis C drug has been dealt a blow after patients suffer relapses in a mid-stage trial.  In the …
News

Pfizer closes in on $545m China generics deal

February 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …
News

Health Information appoints Nigel Brooksby as its deputy chairman

February 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Brooksby, Health Information

Health Information, a provider of medicine adherence services in the UK, has appointed former ABPI president Nigel Brooksby as its …
Appointment

Cimzia results excite UCB in psoriatic arthritis

February 16, 2012 Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis

UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …
News

Panu Miettinen appointed chief financial officer of Biotie

February 16, 2012 Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen

Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies.  He will become a member of the Group’s …
Appointment

MRN launches online training portal

February 16, 2012 Research and Development

16 February 2012 – Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial support, site …
News
Press release

Amgen appoints Michael Severino as senior vice president, Global Development and Corporate chief medical officer

February 16, 2012 Business Services, Research and Development, Sales and Marketing

Michael Severino has been named senior vice president, Global Development and Corporate chief medical officer at Amgen.Severino, 46, formerly vice president, …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026